Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ann Thor

Concepts (458)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
72
2023
2393
3.890
 Why?
Neoplasms, Germ Cell and Embryonal
8
2026
76
2.640
 Why?
Testicular Neoplasms
8
2026
111
2.610
 Why?
Metformin
10
2018
329
1.990
 Why?
Lymph Node Excision
6
2026
173
1.780
 Why?
Tamoxifen
11
2023
193
1.600
 Why?
Receptors, Estrogen
17
2020
404
1.450
 Why?
Thyroid Hormones
2
2023
69
1.400
 Why?
Seminoma
3
2026
20
1.330
 Why?
Biomarkers, Tumor
17
2024
1329
1.210
 Why?
Receptor, ErbB-3
8
2016
48
1.210
 Why?
Lymphatic Metastasis
18
2024
336
1.180
 Why?
Cell Proliferation
16
2023
2514
1.170
 Why?
Genes, erbB-2
8
2013
32
1.020
 Why?
Cell Cycle
5
2023
598
1.010
 Why?
Mammary Neoplasms, Experimental
6
2017
62
0.980
 Why?
MicroRNAs
6
2024
686
0.890
 Why?
Apoptosis
21
2018
2443
0.860
 Why?
Estrogen Receptor alpha
3
2023
151
0.840
 Why?
Estrogens
2
2023
367
0.760
 Why?
Cell Line, Tumor
23
2023
3551
0.750
 Why?
ErbB Receptors
6
2010
635
0.630
 Why?
Up-Regulation
3
2020
848
0.620
 Why?
Hormone Replacement Therapy
1
2020
107
0.600
 Why?
Immunohistochemistry
26
2020
1723
0.580
 Why?
Mammary Neoplasms, Animal
3
2018
35
0.560
 Why?
Triple Negative Breast Neoplasms
3
2016
218
0.550
 Why?
Caspases
5
2009
233
0.540
 Why?
Disease-Free Survival
11
2020
770
0.540
 Why?
Tumor Suppressor Protein p53
14
2011
534
0.510
 Why?
Retroperitoneal Space
3
2026
18
0.500
 Why?
Gene Expression Regulation, Neoplastic
18
2021
1450
0.470
 Why?
Prognosis
21
2020
4329
0.470
 Why?
Antineoplastic Agents
10
2018
2219
0.460
 Why?
Claudins
1
2016
23
0.460
 Why?
Receptor, IGF Type 1
3
2016
64
0.450
 Why?
Drug Resistance, Neoplasm
10
2023
883
0.440
 Why?
Trastuzumab
8
2016
118
0.420
 Why?
Quinazolines
3
2026
266
0.410
 Why?
Transcriptome
1
2020
1042
0.410
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2015
1969
0.400
 Why?
Carcinogenesis
1
2016
228
0.400
 Why?
Carcinoma, Ductal, Breast
5
2002
90
0.400
 Why?
Signal Transduction
16
2023
5223
0.400
 Why?
Postoperative Complications
1
2026
2977
0.380
 Why?
Estradiol
2
2009
515
0.380
 Why?
Genistein
2
2010
13
0.380
 Why?
Humans
95
2026
145763
0.370
 Why?
Receptors, Steroid
2
2012
42
0.370
 Why?
Hypoglycemic Agents
3
2017
1399
0.360
 Why?
Female
69
2026
79035
0.350
 Why?
Doxorubicin
10
2011
403
0.350
 Why?
Antineoplastic Agents, Hormonal
5
2020
196
0.340
 Why?
Antimetabolites, Antineoplastic
1
2012
106
0.340
 Why?
Receptors, Progesterone
6
2020
244
0.330
 Why?
Sweden
3
2026
115
0.320
 Why?
Teratoma
2
2022
124
0.310
 Why?
STAT3 Transcription Factor
1
2012
206
0.310
 Why?
Neoplasm Invasiveness
7
2016
508
0.310
 Why?
Genes, p53
5
2000
67
0.310
 Why?
Neoplasm Staging
9
2024
1474
0.300
 Why?
Mice
18
2023
18355
0.300
 Why?
Neoplasm Proteins
5
2016
442
0.290
 Why?
Glucose
1
2013
1048
0.270
 Why?
Middle Aged
33
2026
36302
0.270
 Why?
Glycoproteins
2
2005
354
0.270
 Why?
Intracellular Signaling Peptides and Proteins
2
2010
457
0.260
 Why?
Mammary Tumor Virus, Mouse
2
2004
42
0.260
 Why?
Mice, Transgenic
8
2018
2191
0.250
 Why?
MCF-7 Cells
4
2020
133
0.240
 Why?
Carcinoma
4
1995
227
0.240
 Why?
Ejaculation
1
2026
11
0.240
 Why?
Animals
23
2023
38097
0.240
 Why?
Neoplasm, Residual
2
2024
143
0.240
 Why?
Antibodies, Monoclonal
7
2013
1505
0.230
 Why?
Bromodeoxyuridine
2
1999
77
0.230
 Why?
Thiophenes
1
2026
117
0.220
 Why?
Multivariate Analysis
8
2005
1547
0.220
 Why?
Polymerase Chain Reaction
6
2021
1043
0.220
 Why?
Predictive Value of Tests
6
2024
2123
0.220
 Why?
Protein Kinase Inhibitors
3
2016
981
0.220
 Why?
Intraoperative Complications
1
2026
157
0.210
 Why?
Enzyme Activation
4
2009
762
0.210
 Why?
Tyrosine
2
2007
217
0.210
 Why?
Radiation Tolerance
1
2005
103
0.210
 Why?
Xenograft Model Antitumor Assays
3
2020
936
0.200
 Why?
Phosphorylation
5
2011
1708
0.200
 Why?
Cocarcinogenesis
1
2003
13
0.200
 Why?
Isoflavones
1
2003
25
0.200
 Why?
Cell Survival
5
2018
1103
0.190
 Why?
Survival Analysis
8
2005
1378
0.190
 Why?
Adult
22
2026
40872
0.190
 Why?
Paclitaxel
4
2015
259
0.190
 Why?
Chromosomes
1
2003
106
0.180
 Why?
Fluorouracil
6
2026
231
0.180
 Why?
Ki-67 Antigen
4
2014
118
0.180
 Why?
Cyclins
2
2000
79
0.180
 Why?
Chromosomes, Human, Pair 8
1
2002
39
0.180
 Why?
Gelsolin
1
2001
10
0.170
 Why?
Chromosome Aberrations
1
2002
166
0.170
 Why?
Orchiectomy
1
2021
72
0.170
 Why?
Cyclophosphamide
7
2011
272
0.170
 Why?
Proto-Oncogene Proteins c-ets
2
2020
56
0.170
 Why?
Breast
4
2018
156
0.170
 Why?
Retroperitoneal Neoplasms
1
2021
28
0.160
 Why?
Rats
7
2022
5585
0.160
 Why?
Caspase 3
4
2006
242
0.160
 Why?
DNA-Binding Proteins
3
2020
1482
0.160
 Why?
Diet
3
2018
1278
0.160
 Why?
Etoposide
1
2001
168
0.160
 Why?
Cell Division
6
2005
757
0.160
 Why?
Obesity
4
2022
3118
0.160
 Why?
Neoplastic Stem Cells
2
2014
409
0.150
 Why?
Mice, SCID
1
2020
369
0.150
 Why?
Phosphatidylinositol 3-Kinases
3
2011
383
0.150
 Why?
Proto-Oncogene Proteins
5
2008
625
0.150
 Why?
Drug Screening Assays, Antitumor
3
2016
194
0.150
 Why?
Transcription Factors
3
2020
1736
0.150
 Why?
TOR Serine-Threonine Kinases
3
2012
456
0.150
 Why?
Treatment Outcome
6
2026
11793
0.150
 Why?
Mitotic Index
1
1999
25
0.150
 Why?
Prospective Studies
4
2024
8075
0.150
 Why?
Carcinoma, Papillary
1
1999
82
0.140
 Why?
Mice, Inbred NOD
1
2020
616
0.140
 Why?
Receptors, Androgen
2
2017
149
0.140
 Why?
Antigens, Neoplasm
2
2009
271
0.140
 Why?
Chemotherapy, Adjuvant
5
2015
427
0.140
 Why?
Tumor Cells, Cultured
6
2009
887
0.140
 Why?
Ovarian Neoplasms
4
1995
595
0.140
 Why?
Drug Synergism
3
2018
354
0.140
 Why?
Aromatase
1
2018
37
0.140
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
58
0.130
 Why?
Kaplan-Meier Estimate
1
2020
971
0.130
 Why?
HSP90 Heat-Shock Proteins
1
2018
47
0.130
 Why?
Phenylthiohydantoin
2
2017
44
0.130
 Why?
Colorectal Neoplasms
1
2026
868
0.130
 Why?
Down-Regulation
3
2010
618
0.130
 Why?
Autism Spectrum Disorder
1
2023
423
0.130
 Why?
In Situ Hybridization, Fluorescence
4
2008
328
0.130
 Why?
Ovariectomy
4
2022
166
0.130
 Why?
Tumor Burden
4
2022
325
0.130
 Why?
Poly(ADP-ribose) Polymerases
2
2009
88
0.130
 Why?
Organic Cation Transport Proteins
1
2017
25
0.120
 Why?
Postmenopause
5
2022
394
0.120
 Why?
Triazoles
1
2018
191
0.120
 Why?
Antibodies, Monoclonal, Humanized
5
2013
992
0.120
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
231
0.120
 Why?
Smad Proteins
1
2016
42
0.120
 Why?
Cathepsin D
2
2002
22
0.120
 Why?
Gene Knock-In Techniques
1
2016
61
0.120
 Why?
Calcitriol
1
2016
58
0.120
 Why?
Ovary
1
2017
234
0.110
 Why?
Antibiotics, Antineoplastic
3
2009
140
0.110
 Why?
Proteins
2
1992
1023
0.110
 Why?
Male
9
2026
73003
0.110
 Why?
Gene Amplification
2
2009
118
0.110
 Why?
Protein Tyrosine Phosphatases
1
2016
167
0.110
 Why?
Fatty Acid Synthase, Type I
1
2014
11
0.110
 Why?
Immunoradiometric Assay
1
1994
1
0.100
 Why?
Immunoprecipitation
2
2011
149
0.100
 Why?
Androgen Receptor Antagonists
1
2014
35
0.100
 Why?
Mental Disorders
1
2023
1169
0.100
 Why?
Young Adult
4
2024
14251
0.100
 Why?
Postpartum Period
2
2014
373
0.100
 Why?
Disease Progression
6
2018
2865
0.100
 Why?
Insulin-Like Growth Factor I
1
2016
317
0.100
 Why?
Mice, Knockout
1
2020
3130
0.100
 Why?
Receptor, ErbB-4
2
2010
18
0.100
 Why?
Androgen Antagonists
1
2014
91
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2010
64
0.100
 Why?
Transforming Growth Factor beta
1
2016
474
0.100
 Why?
Retrospective Studies
5
2026
17325
0.090
 Why?
Blotting, Western
3
2011
1184
0.090
 Why?
Adenocarcinoma
3
2012
926
0.090
 Why?
Aged
15
2026
26215
0.090
 Why?
Overnutrition
1
2012
28
0.090
 Why?
Vitamin D
1
2016
404
0.090
 Why?
Nucleic Acid Hybridization
2
2003
187
0.090
 Why?
DNA, Neoplasm
6
2005
160
0.090
 Why?
Aminosalicylic Acids
1
2012
10
0.090
 Why?
Benzenesulfonates
1
2012
23
0.090
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
61
0.090
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
241
0.090
 Why?
Gene Expression Profiling
2
2016
1777
0.090
 Why?
Chromones
1
2011
43
0.090
 Why?
RNA, Messenger
4
2016
2805
0.090
 Why?
Genital Diseases, Female
1
1991
31
0.090
 Why?
Disease Models, Animal
4
2017
4568
0.080
 Why?
Dasatinib
1
2011
58
0.080
 Why?
Fluoxymesterone
1
1991
1
0.080
 Why?
Apoptosis Regulatory Proteins
1
2012
187
0.080
 Why?
Mitosis
3
2001
193
0.080
 Why?
Proportional Hazards Models
4
2005
1330
0.080
 Why?
S Phase
2
2010
78
0.080
 Why?
Reagent Kits, Diagnostic
1
1991
33
0.080
 Why?
Thiazoles
1
2011
142
0.080
 Why?
Morpholines
1
2011
130
0.080
 Why?
Cohort Studies
2
2020
6032
0.080
 Why?
Weight Gain
3
2022
561
0.080
 Why?
Chromosomes, Human, Pair 17
3
2002
54
0.080
 Why?
Proto-Oncogenes
1
1989
28
0.080
 Why?
Genital Neoplasms, Female
1
1991
99
0.080
 Why?
Neoplasm Metastasis
5
2005
688
0.080
 Why?
Radioisotopes
1
1989
37
0.080
 Why?
Dose-Response Relationship, Drug
2
2008
2028
0.080
 Why?
Flow Cytometry
3
2007
1165
0.070
 Why?
DNA Topoisomerases, Type II
1
2009
42
0.070
 Why?
Anthracyclines
1
2009
49
0.070
 Why?
Follow-Up Studies
5
2020
5428
0.070
 Why?
Aged, 80 and over
6
2002
8346
0.070
 Why?
Gene Deletion
2
2002
392
0.070
 Why?
MAP Kinase Signaling System
1
2010
308
0.070
 Why?
AMP-Activated Protein Kinases
1
2009
192
0.070
 Why?
RNA, Small Interfering
2
2007
638
0.070
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
979
0.070
 Why?
Pyrimidines
1
2011
530
0.070
 Why?
Epithelial Cells
1
2014
1134
0.070
 Why?
Mice, Nude
1
2009
680
0.060
 Why?
Gene Dosage
1
2008
145
0.060
 Why?
Mutation
3
1995
4090
0.060
 Why?
Protein Structure, Tertiary
1
2009
855
0.060
 Why?
Reproducibility of Results
3
2023
3416
0.060
 Why?
Immunoenzyme Techniques
3
1999
200
0.060
 Why?
Time Factors
4
2015
7133
0.060
 Why?
Proto-Oncogene Proteins c-akt
3
2016
440
0.060
 Why?
Energy Metabolism
1
2012
935
0.060
 Why?
Enzyme Precursors
1
2006
15
0.060
 Why?
Thymidylate Synthase
1
2026
13
0.060
 Why?
Cell Nucleus
4
2006
588
0.060
 Why?
Receptor, Notch1
1
2006
63
0.060
 Why?
Aging
4
2003
1973
0.060
 Why?
Multigene Family
2
2003
210
0.060
 Why?
Lamin Type B
1
2005
6
0.060
 Why?
Epigenesis, Genetic
1
2010
693
0.060
 Why?
Herpes Simplex
1
2006
99
0.060
 Why?
Mitochondria
3
2008
992
0.060
 Why?
Herpesvirus 1, Human
1
2006
84
0.050
 Why?
Survival Rate
4
2020
2094
0.050
 Why?
Cell Nucleolus
1
2005
20
0.050
 Why?
Age Factors
3
2003
3346
0.050
 Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
106
0.050
 Why?
Benzamides
2
2017
226
0.050
 Why?
Antineoplastic Agents, Phytogenic
2
2007
178
0.050
 Why?
Nitriles
2
2017
211
0.050
 Why?
Feedback
1
2005
180
0.050
 Why?
RNA Interference
3
2015
475
0.050
 Why?
Protein Kinases
1
2006
312
0.050
 Why?
Tacrolimus Binding Protein 1A
1
2003
10
0.050
 Why?
Tumor Microenvironment
2
2018
735
0.050
 Why?
Tacrolimus Binding Proteins
1
2003
25
0.050
 Why?
Rats, Wistar
2
2017
450
0.050
 Why?
Mice, Inbred Strains
1
2004
396
0.050
 Why?
Estrogens, Non-Steroidal
1
2003
10
0.050
 Why?
Genes, Tumor Suppressor
1
2003
85
0.050
 Why?
Phytoestrogens
1
2003
17
0.050
 Why?
Adipose Tissue
2
2018
645
0.050
 Why?
Estrogen Antagonists
1
2003
37
0.050
 Why?
Plant Preparations
1
2003
37
0.050
 Why?
Cell Line
2
2003
2823
0.050
 Why?
Actins
1
2005
426
0.050
 Why?
Anticarcinogenic Agents
1
2003
63
0.050
 Why?
Chromosome Banding
1
2002
19
0.050
 Why?
Chromosomes, Human, Pair 16
1
2002
36
0.050
 Why?
Mammary Glands, Animal
1
2003
128
0.050
 Why?
Embryoid Bodies
1
2022
8
0.050
 Why?
Transfection
3
2015
927
0.040
 Why?
3' Untranslated Regions
2
2014
149
0.040
 Why?
Rodentia
1
2022
61
0.040
 Why?
Trefoil Factor-1
2
1992
2
0.040
 Why?
Fallopian Tubes
2
1991
33
0.040
 Why?
alpha-Fetoproteins
1
2021
42
0.040
 Why?
In Situ Nick-End Labeling
1
2001
120
0.040
 Why?
Chorionic Gonadotropin
1
2021
78
0.040
 Why?
RNA, Catalytic
1
2002
191
0.040
 Why?
Nuclear Proteins
2
2000
740
0.040
 Why?
DNA Fragmentation
1
2001
40
0.040
 Why?
Plasmids
1
2002
373
0.040
 Why?
Inhibitory Concentration 50
1
2001
91
0.040
 Why?
Fibrosis
1
2023
561
0.040
 Why?
RNA Stability
1
2021
107
0.040
 Why?
Antigens, Nuclear
1
2000
15
0.040
 Why?
Breast Diseases
1
2000
23
0.040
 Why?
Enhancer Elements, Genetic
1
2000
191
0.040
 Why?
Integrin beta3
2
2013
14
0.040
 Why?
Telomerase
1
2001
246
0.040
 Why?
Tumor Suppressor Proteins
2
1992
322
0.040
 Why?
N-Glycosyl Hydrolases
1
1998
6
0.040
 Why?
Methylnitrosourea
1
2018
7
0.040
 Why?
DNA Glycosylases
1
1998
10
0.030
 Why?
Loss of Function Mutation
1
2018
45
0.030
 Why?
G2 Phase Cell Cycle Checkpoints
1
2018
44
0.030
 Why?
Trans-Activators
1
2000
396
0.030
 Why?
Antibodies
1
2000
397
0.030
 Why?
NF-kappa B
1
2002
667
0.030
 Why?
Codon
3
1993
92
0.030
 Why?
Half-Life
1
2018
155
0.030
 Why?
Case-Control Studies
2
2023
3634
0.030
 Why?
Stromal Cells
1
2018
121
0.030
 Why?
Hyaluronan Receptors
1
1998
104
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
165
0.030
 Why?
Gene Expression
3
2013
1478
0.030
 Why?
Organic Cation Transporter 2
1
2017
8
0.030
 Why?
Cell Movement
1
2001
961
0.030
 Why?
Extracellular Matrix Proteins
1
1998
156
0.030
 Why?
Steroids
1
2017
160
0.030
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2016
14
0.030
 Why?
Antigens, CD
2
2014
558
0.030
 Why?
DNA Repair
1
1998
255
0.030
 Why?
Oncogenes
1
2016
118
0.030
 Why?
Phosphatidylinositol 3-Kinase
1
2015
25
0.030
 Why?
Chromatography, Liquid
1
2017
450
0.030
 Why?
Oncogene Proteins
1
1995
62
0.030
 Why?
RNA
1
2001
912
0.030
 Why?
Analysis of Variance
2
2014
1300
0.030
 Why?
Homeodomain Proteins
1
2018
523
0.030
 Why?
Tosyl Compounds
1
2014
17
0.030
 Why?
Gene Expression Regulation, Enzymologic
1
2015
267
0.030
 Why?
Mammary Glands, Human
1
2014
68
0.030
 Why?
Integrin alpha6
1
2013
9
0.030
 Why?
Mass Spectrometry
1
2017
731
0.030
 Why?
Leukocyte Common Antigens
1
2014
87
0.030
 Why?
Adolescent
3
2024
22573
0.030
 Why?
Antigens, Differentiation, Myelomonocytic
1
2014
66
0.030
 Why?
Parity
1
2014
111
0.020
 Why?
Neovascularization, Pathologic
1
1995
287
0.020
 Why?
Immunoassay
1
1994
109
0.020
 Why?
Anilides
1
2014
84
0.020
 Why?
Premenopause
1
2014
125
0.020
 Why?
Transplantation, Heterologous
1
2014
170
0.020
 Why?
Neoplasm Transplantation
1
2014
246
0.020
 Why?
Testosterone
1
2017
416
0.020
 Why?
bcl-2-Associated X Protein
2
2007
53
0.020
 Why?
Tomography, X-Ray Computed
1
2024
2770
0.020
 Why?
Sirolimus
2
2006
282
0.020
 Why?
Interleukin-6
1
2017
779
0.020
 Why?
Organ Specificity
1
2013
309
0.020
 Why?
Inhibitor of Apoptosis Proteins
1
2013
46
0.020
 Why?
Immune System
1
2014
180
0.020
 Why?
Lactation
1
2014
193
0.020
 Why?
Lipogenesis
1
2012
62
0.020
 Why?
Brain Neoplasms
2
1993
1331
0.020
 Why?
Point Mutation
1
1993
241
0.020
 Why?
Molecular Targeted Therapy
1
2015
440
0.020
 Why?
Tumor Necrosis Factor-alpha
2
2007
1217
0.020
 Why?
Neoplasms
2
2012
2913
0.020
 Why?
Astrocytoma
1
1993
130
0.020
 Why?
Broad Ligament
1
1991
1
0.020
 Why?
Gene Knockdown Techniques
1
2013
334
0.020
 Why?
Peritoneum
1
1991
43
0.020
 Why?
Mucins
1
1991
75
0.020
 Why?
Pregnancy Complications, Neoplastic
1
1991
63
0.020
 Why?
Blotting, Northern
1
2010
203
0.020
 Why?
Glycolysis
1
2012
340
0.020
 Why?
Evaluation Studies as Topic
1
1991
164
0.020
 Why?
Hormones
1
1991
135
0.020
 Why?
Cells, Cultured
2
2013
4151
0.020
 Why?
In Situ Hybridization
1
2010
318
0.020
 Why?
Soft Tissue Neoplasms
1
1991
131
0.020
 Why?
Precipitin Tests
1
1989
90
0.020
 Why?
Pilot Projects
1
2015
1897
0.020
 Why?
Pregnancy
2
2014
7215
0.020
 Why?
Radionuclide Imaging
1
1989
116
0.020
 Why?
Odds Ratio
1
1992
1083
0.020
 Why?
Glioblastoma
1
1993
354
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
751
0.020
 Why?
Protein Multimerization
1
2010
205
0.020
 Why?
Risk Factors
1
2003
10917
0.020
 Why?
Lymph Nodes
1
1991
509
0.020
 Why?
Drug Interactions
1
2009
405
0.020
 Why?
Cytochromes c
1
2007
53
0.020
 Why?
Membrane Potential, Mitochondrial
1
2007
74
0.020
 Why?
Apoptotic Protease-Activating Factor 1
1
2007
2
0.020
 Why?
Caspase 10
1
2006
5
0.020
 Why?
Caspase 2
1
2006
12
0.020
 Why?
Amino Acid Sequence
3
1998
2131
0.020
 Why?
Caspase 8
1
2006
48
0.020
 Why?
Caspase 9
1
2006
55
0.020
 Why?
Cysteine Endopeptidases
1
2006
78
0.020
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2006
17
0.020
 Why?
Caspase 7
1
2006
22
0.010
 Why?
Isoenzymes
1
2007
295
0.010
 Why?
Eukaryotic Initiation Factor-4E
1
2006
32
0.010
 Why?
Vero Cells
1
2006
83
0.010
 Why?
Cytosol
1
2006
213
0.010
 Why?
Biomarkers
1
2017
4302
0.010
 Why?
Base Sequence
2
2003
2171
0.010
 Why?
Promoter Regions, Genetic
1
2010
1247
0.010
 Why?
Virus Assembly
1
2006
82
0.010
 Why?
Taxoids
1
2004
114
0.010
 Why?
Protein Binding
1
2010
2240
0.010
 Why?
DNA, Complementary
1
2003
273
0.010
 Why?
Protein Processing, Post-Translational
1
2006
473
0.010
 Why?
Melanoma, Experimental
1
2003
109
0.010
 Why?
Americas
1
2002
27
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2002
25
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
78
0.010
 Why?
Endothelial Growth Factors
1
2002
62
0.010
 Why?
Lymphokines
1
2002
128
0.010
 Why?
Plasminogen Activator Inhibitor 1
1
2002
85
0.010
 Why?
Platelet Membrane Glycoproteins
1
2002
31
0.010
 Why?
Cell Adhesion
1
2003
451
0.010
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2002
50
0.010
 Why?
Gene Targeting
1
2002
81
0.010
 Why?
Exons
2
1993
364
0.010
 Why?
Mice, Inbred C57BL
2
2003
5992
0.010
 Why?
Europe
1
2002
421
0.010
 Why?
Templates, Genetic
1
2001
63
0.010
 Why?
Molecular Sequence Data
2
1998
2883
0.010
 Why?
Substrate Specificity
1
2002
387
0.010
 Why?
DNA, Superhelical
1
2000
12
0.010
 Why?
DNA Footprinting
1
2000
33
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2002
376
0.010
 Why?
Mice, Inbred BALB C
1
2003
1261
0.010
 Why?
Data Interpretation, Statistical
1
2002
368
0.010
 Why?
Genes, erbB
1
2000
2
0.010
 Why?
Ploidies
1
2000
20
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
117
0.010
 Why?
Macromolecular Substances
1
2000
216
0.010
 Why?
Pathology, Clinical
1
2000
29
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2002
552
0.010
 Why?
Gene Silencing
1
2000
202
0.010
 Why?
Forecasting
1
2000
390
0.010
 Why?
Multicenter Studies as Topic
1
2000
413
0.010
 Why?
Genetic Therapy
1
2000
316
0.010
 Why?
Receptors, Cell Surface
1
2000
372
0.010
 Why?
Nucleic Acid Conformation
1
2000
723
0.010
 Why?
Binding Sites
1
2000
1311
0.010
 Why?
Chromosomes, Human, Pair 13
1
1996
15
0.010
 Why?
ras Proteins
1
1998
150
0.010
 Why?
Chromosomes, Human, Pair 3
1
1996
43
0.010
 Why?
Chromosomes, Human, Pair 11
1
1996
59
0.010
 Why?
Immunoblotting
1
1997
295
0.010
 Why?
Heterozygote
1
1996
314
0.010
 Why?
Societies, Medical
1
2000
900
0.010
 Why?
Hyaluronic Acid
1
1998
226
0.010
 Why?
Adenine
1
1998
339
0.010
 Why?
Polymorphism, Single-Stranded Conformational
1
1995
26
0.010
 Why?
Protein Isoforms
1
1997
399
0.010
 Why?
Melanoma
1
2002
761
0.010
 Why?
Cyclin D1
1
1995
64
0.010
 Why?
Factor VIII
1
1995
106
0.010
 Why?
Single-Blind Method
1
1995
318
0.010
 Why?
United States
2
2004
16123
0.010
 Why?
Observer Variation
1
1995
357
0.010
 Why?
Transcription, Genetic
1
2000
1454
0.010
 Why?
Randomized Controlled Trials as Topic
1
2000
1751
0.010
 Why?
Alleles
1
1996
896
0.010
 Why?
Biopsy
1
1995
1082
0.010
 Why?
Proliferating Cell Nuclear Antigen
1
1991
48
0.010
 Why?
Peripheral Nerves
1
1991
72
0.000
 Why?
DNA
1
1996
1437
0.000
 Why?
Polymorphism, Genetic
1
1993
615
0.000
 Why?
Risk Assessment
1
2000
3752
0.000
 Why?
Protein Conformation
1
1993
938
0.000
 Why?
Lung Neoplasms
1
2002
2667
0.000
 Why?
Cerebral Cortex
1
1991
474
0.000
 Why?
Glioma
1
1991
429
0.000
 Why?
Child
1
1993
22739
0.000
 Why?
Thor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (458) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)